Clinical Trial Update: Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4? [Phase 4]

View source ↗

Summary

A Phase 4 trial update investigates whether pioglitazone increases production of 15-EPI-Lipoxin A4 in individuals with Type 2 Diabetes Mellitus; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-06-22